Quarterly report pursuant to Section 13 or 15(d)

5. COMMON STOCK TRANSACTIONS (Details Narrative)

v3.20.4
5. COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)
2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 01, 2018
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Apr. 30, 2019
Shelf Offering [Member]            
Stock issued new, shares       693,000,000 137,000,000  
Proceeds from sale of equity       $ 4,700,000 $ 884,000  
Common Stock [Member] | Director Letter Agreement [Member] | Four Nonemployees [Member]            
Stock issued for compensation, shares         2,000,000  
Stock based compensation expense   $ 0 $ 18,988 $ 10,561 $ 46,433  
Unvested shares   0 0 0 0  
Common Stock [Member] | Director Letter Agreement [Member] | Four Nonemployee [Member]            
Stock issued for compensation, shares       2,000,000    
Stock based compensation expense   $ 10,411 $ 10,411 $ 26,859 $ 26,859  
Unvested shares   0   0    
Common Stock [Member] | Consulting Agreement [Member] | A Consultant [Member]            
Stock issued for compensation, shares 1,200,000          
Stock based compensation expense   $ 0 $ 0 $ 0 $ 12,816  
Unvested shares   0 0 0 0  
Common Stock [Member] | Consulting Agreement [Member] | A Consultant [Member]            
Stock based compensation expense   $ 0 $ 0 $ 0 $ 17,350  
Unvested shares   0 0 0 0  
Stock to be issued for compensation, shares         500,000  
Common Stock [Member] | Consulting Agreements [Member] | Two Consultants [Member]            
Stock issued for compensation, shares           2,500,000
Stock based compensation expense   $ 0 $ 0 $ 0 $ 11,910  
Unvested shares   0 0 0 0  
Common Stock [Member] | Consulting Agreements [Member] | Four Consultants [Member]            
Stock issued for compensation, shares       1,000,000    
Stock based compensation expense   $ 5,409 $ 5,409 $ 15,017 $ 15,017  
Unvested shares   250,000   250,000    
Common Stock [Member] | 2019 Compensation Agreement [Member] | Officers [Member]            
Stock issued for compensation, shares         6,600,000  
Stock based compensation expense   $ 0 $ 69,438 $ 0 $ 278,891  
Unvested shares   0 0 0 0  
Common Stock [Member] | Medical And Scientific Advisory Board [Member] | A Consultant [Member]            
Stock issued for compensation, shares         2,000,000  
Stock based compensation expense   $ 0 $ 0 $ 0 $ 11,851  
Unvested shares   0 0 0 0  
Common Stock [Member] | Medical And Scientific Advisory Board [Member] | A Consultant [Member]            
Stock issued for compensation, shares       500,000    
Stock based compensation expense   $ 2,125 $ 0 $ 2,833 $ 0  
Unvested shares   0 0 0 0  
Common Stock [Member] | 2020 Compensation Agreement [Member] | Officers [Member]            
Stock issued for compensation, shares         6,600,000  
Stock based compensation expense   $ 44,881 $ 30,800 $ 179,521 $ 30,800  
Unvested shares   0 6,050,000 0 6,050,000  
Common Stock [Member] | 2021 Compensation Agreement [Member] | Executive Officer [Member]            
Stock issued for compensation, shares       6,600,000    
Stock based compensation expense   $ 3,685   $ 3,685    
Unvested shares   6,050,000   6,050,000    
Common Stock [Member] | Four Directors [Member] | Director Letter Agreement [Member]            
Stock issued for compensation, shares         2,000,000  
Stock based compensation expense   $ 0 $ 0 $ 0 $ 19,212  
Unvested shares   0   0